The spectrum of Malassezia infections in the bone marrow transplant population - PubMed (original) (raw)
The spectrum of Malassezia infections in the bone marrow transplant population
V A Morrison et al. Bone Marrow Transplant. 2000 Sep.
Abstract
A consecutive series of 3044 patients who underwent BMT at the University of Minnesota over a 25 year period were reviewed for the post-transplant occurrence of infection caused by the yeast Malassezia furfur. Six patients, ranging in age from 1 to 54 years, developed Malassezia infections at a median of 59 days post transplant. Five patients were allogeneic transplant recipients; the remaining patient had undergone autologous transplantation. A spectrum of clinical manifestations of Malassezia infection was seen in these patients, including infections of mucosal surfaces and the skin, in addition to catheter-related fungemia. Unlike many of the other more common opportunistic fungal infections in immunocompromised patients, neutropenia and the use of broad-spectrum antimicrobials do not appear to be significant risk factors for Malassezia infections in the BMT population. In addition, disseminated fungal infection despite the presence of fungemia is uncommon. Lastly, the outcome of Malassezia infections in these patients, whether folliculitis, mucosal infection, or fungemia, appears to be quite favorable, in contrast to the poorer outcome with many other fungal infections in BMT patients. Catheter removal and discontinuation of intravenous lipids are important for a successful outcome in fungemic cases.
Similar articles
- Malassezia: is it a pulmonary pathogen in the stem cell transplant population?
Blaes AH, Cavert WP, Morrison VA. Blaes AH, et al. Transpl Infect Dis. 2009 Aug;11(4):313-7. doi: 10.1111/j.1399-3062.2009.00404.x. Epub 2009 May 11. Transpl Infect Dis. 2009. PMID: 19497074 - Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J. Safdar A, et al. Bone Marrow Transplant. 2001 Nov;28(9):873-8. doi: 10.1038/sj.bmt.1703252. Bone Marrow Transplant. 2001. PMID: 11781648 - Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V, Khan SA, Finiewicz KJ, Nguyen H, Clancy CJ, Mehta PS, Wingard JR. Grow WB, et al. Bone Marrow Transplant. 2002 Jan;29(1):15-9. doi: 10.1038/sj.bmt.1703332. Bone Marrow Transplant. 2002. PMID: 11840139 - Minireview: Malassezia infections in immunocompromised patients.
Tragiannidis A, Bisping G, Koehler G, Groll AH. Tragiannidis A, et al. Mycoses. 2010 May;53(3):187-95. doi: 10.1111/j.1439-0507.2009.01814.x. Epub 2009 Dec 17. Mycoses. 2010. PMID: 20028460 Review. - Tuberculosis in blood and marrow transplant recipients.
Yuen KY, Woo PC. Yuen KY, et al. Hematol Oncol. 2002 Jun;20(2):51-62. doi: 10.1002/hon.681. Hematol Oncol. 2002. PMID: 12111868 Review.
Cited by
- The Malassezia genus in skin and systemic diseases.
Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. Gaitanis G, et al. Clin Microbiol Rev. 2012 Jan;25(1):106-41. doi: 10.1128/CMR.00021-11. Clin Microbiol Rev. 2012. PMID: 22232373 Free PMC article. Review. - In Vitro or In Vivo Models, the Next Frontier for Unraveling Interactions between Malassezia spp. and Hosts. How Much Do We Know?
Torres M, de Cock H, Celis Ramírez AM. Torres M, et al. J Fungi (Basel). 2020 Aug 28;6(3):155. doi: 10.3390/jof6030155. J Fungi (Basel). 2020. PMID: 32872112 Free PMC article. Review. - Successful Treatment of Malassezia furfur Endocarditis.
Granok AB. Granok AB. Open Forum Infect Dis. 2020 Jan 27;7(8):ofaa029. doi: 10.1093/ofid/ofaa029. eCollection 2020 Aug. Open Forum Infect Dis. 2020. PMID: 32855981 Free PMC article. - Malassezia restricta Pneumonia in Solid Organ Transplant Recipients: First Report of Two Cases.
Mularoni A, Graziano E, Medaglia AA, Buscemi B, Eddens T, Martino L, Di Carlo D, Cascio A, Conaldi PG, Bertani A, Grossi PA. Mularoni A, et al. J Fungi (Basel). 2021 Dec 10;7(12):1057. doi: 10.3390/jof7121057. J Fungi (Basel). 2021. PMID: 34947039 Free PMC article. - Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years: The Experience of Fluconazole Prophylaxis in a Single Hospital.
Chen IT, Chen CC, Huang HC, Kuo KC. Chen IT, et al. Adv Neonatal Care. 2020 Feb;20(1):E3-E8. doi: 10.1097/ANC.0000000000000640. Adv Neonatal Care. 2020. PMID: 31306235 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical